Kidney Disease, Chronic Clinical Trials in Cleveland, Ohio
2 recruitingCleveland, Ohio
Showing 1–2 of 2 trials
Recruiting
Phase 3
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Kidney Disease, Chronic
Boehringer Ingelheim11,000 enrolled452 locationsNCT06531824
Recruiting
APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)
Kidney Disease, ChronicKidney DiseasesKidney Failure
Wake Forest University Health Sciences5,000 enrolled18 locationsNCT03615235